349 related articles for article (PubMed ID: 25423288)
1. Intestinal permeability study of minoxidil: assessment of minoxidil as a high permeability reference drug for biopharmaceutics classification.
Ozawa M; Tsume Y; Zur M; Dahan A; Amidon GL
Mol Pharm; 2015 Jan; 12(1):204-11. PubMed ID: 25423288
[TBL] [Abstract][Full Text] [Related]
2. Comparison of the permeability of metoprolol and labetalol in rat, mouse, and Caco-2 cells: use as a reference standard for BCS classification.
Incecayir T; Tsume Y; Amidon GL
Mol Pharm; 2013 Mar; 10(3):958-66. PubMed ID: 23327720
[TBL] [Abstract][Full Text] [Related]
3. Segmental dependent transport of low permeability compounds along the small intestine due to P-glycoprotein: the role of efflux transport in the oral absorption of BCS class III drugs.
Dahan A; Amidon GL
Mol Pharm; 2009; 6(1):19-28. PubMed ID: 19248230
[TBL] [Abstract][Full Text] [Related]
4. The biopharmaceutics of successful controlled release drug product: Segmental-dependent permeability of glipizide vs. metoprolol throughout the intestinal tract.
Zur M; Cohen N; Agbaria R; Dahan A
Int J Pharm; 2015 Jul; 489(1-2):304-10. PubMed ID: 25957705
[TBL] [Abstract][Full Text] [Related]
5. Multiple efflux pumps are involved in the transepithelial transport of colchicine: combined effect of p-glycoprotein and multidrug resistance-associated protein 2 leads to decreased intestinal absorption throughout the entire small intestine.
Dahan A; Sabit H; Amidon GL
Drug Metab Dispos; 2009 Oct; 37(10):2028-36. PubMed ID: 19589874
[TBL] [Abstract][Full Text] [Related]
6. The suitability of an in situ perfusion model for permeability determinations: utility for BCS class I biowaiver requests.
Kim JS; Mitchell S; Kijek P; Tsume Y; Hilfinger J; Amidon GL
Mol Pharm; 2006; 3(6):686-94. PubMed ID: 17140256
[TBL] [Abstract][Full Text] [Related]
7. MRP2 mediated drug-drug interaction: indomethacin increases sulfasalazine absorption in the small intestine, potentially decreasing its colonic targeting.
Dahan A; Amidon GL
Int J Pharm; 2010 Feb; 386(1-2):216-20. PubMed ID: 19944137
[TBL] [Abstract][Full Text] [Related]
8. The Role of Paracellular Transport in the Intestinal Absorption and Biopharmaceutical Characterization of Minoxidil.
Markovic M; Zur M; Garsiani S; Porat D; Cvijić S; Amidon GL; Dahan A
Pharmaceutics; 2022 Jun; 14(7):. PubMed ID: 35890257
[TBL] [Abstract][Full Text] [Related]
9. Small intestinal efflux mediated by MRP2 and BCRP shifts sulfasalazine intestinal permeability from high to low, enabling its colonic targeting.
Dahan A; Amidon GL
Am J Physiol Gastrointest Liver Physiol; 2009 Aug; 297(2):G371-7. PubMed ID: 19541926
[TBL] [Abstract][Full Text] [Related]
10. High-permeability criterion for BCS classification: segmental/pH dependent permeability considerations.
Dahan A; Miller JM; Hilfinger JM; Yamashita S; Yu LX; Lennernäs H; Amidon GL
Mol Pharm; 2010 Oct; 7(5):1827-34. PubMed ID: 20701326
[TBL] [Abstract][Full Text] [Related]
11. Caco-2 cells and Biopharmaceutics Classification System (BCS) for prediction of transepithelial transport of xenobiotics (model drug: caffeine).
Smetanova L; Stetinova V; Kholova D; Kvetina J; Smetana J; Svoboda Z
Neuro Endocrinol Lett; 2009; 30 Suppl 1():101-5. PubMed ID: 20027153
[TBL] [Abstract][Full Text] [Related]
12. Transintestinal transport mechanisms of 5-aminosalicylic acid (in situ rat intestine perfusion, Caco-2 cells) and Biopharmaceutics Classification System.
Smetanová L; Stětinová V; Kholová D; Kuneš M; Nobilis M; Svoboda Z; Květina J
Gen Physiol Biophys; 2013 Sep; 32(3):361-9. PubMed ID: 23846255
[TBL] [Abstract][Full Text] [Related]
13. The low/high BCS permeability class boundary: physicochemical comparison of metoprolol and labetalol.
Zur M; Gasparini M; Wolk O; Amidon GL; Dahan A
Mol Pharm; 2014 May; 11(5):1707-14. PubMed ID: 24735251
[TBL] [Abstract][Full Text] [Related]
14. Biopharmaceutics classification and intestinal absorption study of apigenin.
Zhang J; Liu D; Huang Y; Gao Y; Qian S
Int J Pharm; 2012 Oct; 436(1-2):311-7. PubMed ID: 22796171
[TBL] [Abstract][Full Text] [Related]
15. Biopharmaceutics permeability classification of lorcaserin, a selective 5-hydroxytryptamine 2C agonist: method suitability and permeability class membership.
Chen C; Ma MG; Fullenwider CL; Chen WG; Sadeque AJ
Mol Pharm; 2013 Dec; 10(12):4739-45. PubMed ID: 24102111
[TBL] [Abstract][Full Text] [Related]
16. Biopharmaceutic Risk Assessment of Brand and Generic Lamotrigine Tablets.
Vaithianathan S; Raman S; Jiang W; Ting TY; Kane MA; Polli JE
Mol Pharm; 2015 Jul; 12(7):2436-43. PubMed ID: 26001027
[TBL] [Abstract][Full Text] [Related]
17. Caco-2 cells, biopharmaceutics classification system (BCS) and biowaiver.
Smetanová L; Stĕtinová V; Svoboda Z; Kvetina J
Acta Medica (Hradec Kralove); 2011; 54(1):3-8. PubMed ID: 21542416
[TBL] [Abstract][Full Text] [Related]
18. Caco-2 versus Caco-2/HT29-MTX co-cultured cell lines: permeabilities via diffusion, inside- and outside-directed carrier-mediated transport.
Hilgendorf C; Spahn-Langguth H; Regårdh CG; Lipka E; Amidon GL; Langguth P
J Pharm Sci; 2000 Jan; 89(1):63-75. PubMed ID: 10664539
[TBL] [Abstract][Full Text] [Related]
19. pH-Dependent solubility and permeability criteria for provisional biopharmaceutics classification (BCS and BDDCS) in early drug discovery.
Varma MV; Gardner I; Steyn SJ; Nkansah P; Rotter CJ; Whitney-Pickett C; Zhang H; Di L; Cram M; Fenner KS; El-Kattan AF
Mol Pharm; 2012 May; 9(5):1199-212. PubMed ID: 22489626
[TBL] [Abstract][Full Text] [Related]
20. The Effect of Excipients on the Permeability of BCS Class III Compounds and Implications for Biowaivers.
Parr A; Hidalgo IJ; Bode C; Brown W; Yazdanian M; Gonzalez MA; Sagawa K; Miller K; Jiang W; Stippler ES
Pharm Res; 2016 Jan; 33(1):167-76. PubMed ID: 26286187
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
